Live streamers may bear advertising liability. Commercial banks may calculate their exposure to the default risk of the derivative transaction counterparty on a net basis. Beijing is the first in the country to permit paid autonomous driving travel experience services.
China Law News
- December 17, 2021
OFAC prohibits U.S. investments in AI company SenseTime, Hong Kong listing postponed; CBIRC to remove foreign ownership cap for insurance asset management firms; MIIT orders removal of 106 apps over data violations
December 14, 2021CBIRC allows involvement of insurance capital in securities lending. SAMR sets forth criteria for calculating illegal income. Disability compensation equality for urban and rural residents.
December 10, 2021Public outrage at Canada Goose's discriminatory return policy; SEC rules implement submission and disclosure requirements for U.S.-listed foreign companies; e-cigarettes to be regulated as a tobacco product
December 07, 2021Shanghai protects the personality and property rights of natural persons in their personal information. Insurance group companies are allowed to invest in non-insurance subsidiaries. Guangdong issues rules on qualified domestic limited partnerships.
December 03, 2021BRI projects face a multiplicity of issues from procurement to implementation. Investors must thoroughly understand and mitigate risks associated with BRI ventures.
December 03, 2021The U.S. adds 12 Chinese entities to its export blacklist; Rules regulating listed companies to be consolidated; Didi ordered by regulators to delist from NYSE
November 30, 2021New rules are set forth for foreign-related certification. More details are required for working papers of securities offering sponsorship. Domestic bond credit rating is relied on more for insurance capital investment.
November 26, 2021Hong Kong finalizes secondary listing reforms to attract more Greater China Issuers; SAMR fines tech giants for failing to declare transactions; and German insurer Allianz approved to take full control of life insurance business
November 23, 2021In China's first-ever securities class action, Kangmei Pharmaceuticals has been ordered to pay $385 million as compensation—just enough for 50,000 investors to recoup their losses.
November 22, 2021






